Date: May 3, 2016
Time: 4:30 PM EST
Listen via Internet: http://ir.vivus.com/
Webcast Link: http://edge.media-server.com/m/p/noazcbiy
Dial in: 1-224-357-2386
Dial in (Toll-Free): 1-877-359-2916
Audience Passcode: 8875 9885
A webcast replay will be available on the VIVUS website for 30 days.
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2015 as filed on March 9, 2016 and periodic reports filed with the Securities and Exchange Commission.
Chief Financial Officer
News Provided by Acquire Media